Related Experiment Video
Updated: Apr 23, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
394
Lobular neoplasia: morphology and management
Julie Jorns1, Michael S Sabel, Judy C Pang
1From the Departments of Pathology (Drs Jorns and Pang) and Surgery (Dr Sabel), University of Michigan Hospital and Health Systems, Ann Arbor.
Archives of Pathology & Laboratory Medicine
|October 1, 2014
Summary
Distinguishing between classic lobular neoplasia and pleomorphic lobular carcinoma in situ is crucial. Management differs, focusing on risk reduction for classic types and lesion eradication for pleomorphic types.
Area of Science:
- Pathology
- Oncology
- Breast Imaging
Background:
- Lobular neoplasia presents a spectrum of conditions, from atypical lobular hyperplasia to lobular carcinoma in situ.
- Classic lobular neoplasia is primarily a risk marker for breast cancer.
- Pleomorphic lobular carcinoma in situ is considered a more aggressive subtype and potential cancer precursor.
Observation:
- This review highlights the morphologic spectrum of lobular neoplasia through three illustrative cases.
- Diagnostic challenges and areas of controversy in lobular neoplasia are addressed.
- Current management recommendations are synthesized based on literature and guidelines.
Findings:
- Accurate classification of lobular neoplasia subtypes is critical for appropriate patient management.
- Pleomorphic lobular carcinoma in situ requires treatment similar to ductal carcinoma in situ.
- Classic lobular neoplasia management focuses on risk reduction strategies.
Implications:
- Differentiated management strategies for lobular neoplasia subtypes can optimize patient outcomes.
- Clearer diagnostic criteria for lobular neoplasia are needed to guide clinical decisions.
- Further research into the precursor role of pleomorphic lobular carcinoma in situ may refine treatment paradigms.
